DNA X, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

DNA X, Inc. reported Cash And Cash Equivalents At Carrying Value of $5.34 million for the year ending 2024.

  • DNA X, Inc. showed a decrease of -43.1% in Cash And Cash Equivalents At Carrying Value from 2023 to 2024.
  • This data is from DNA X, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
  • XBRL data for this metric is available from 2018 to 2024 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2018 to 2024), DNA X, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 59.1%.
  • Historical annual values: Fiscal year 2024: $5.34 million | Fiscal year 2023: $9.40 million | Fiscal year 2022: $13.21 million | Fiscal year 2021: $11.23 million | Fiscal year 2020: $22.14 million | Fiscal year 2019: $11.30 million | Fiscal year 2018: $13.05 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: